Skip to Main Content

Paper Details

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.
Blood Cancer Discov
38
2021
AML, CD93, CD93 CAR, CD93 CAR T cells, Chimeric antigen receptor, Chimeric antigen receptor (CAR) T cells, HSPC, HSPCs, NOT, NOT-Gated CD93 CAR T Cells, NOT-gated CD93 CAR T cells, T cells, acute myeloid leukemia, endothelial cell lines, endothelial cells, hematopoietic stem and progenitor cells, human, human endothelial cells, humanized
Author NameAffiliation
Poul H SorensenBritish Columbia Cancer Research Centre
Poul H SorensenBritish Columbia Cancer Research Centre
Howard Y ChangCenter for Personal Dynamic Regulomes, Stanford University School of Medicine
Howard Y ChangHoward Hughes Medical Institute, Stanford University School of Medicine
Howard Y ChangParker Institute for Cancer Immunotherapy, Stanford University School of Medicine
Ansuman T SatpathyStanford University School of Medicine
Ravindra MajetiStanford University
Ravindra MajetiStanford Cancer Institute, Stanford School of Medicine
Ravindra MajetiCancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
  • 1 - 9

Datasets

Release 1.2